Compare AU

Compare MCCL vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

Munro Climate Change Leaders Fund Active ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are MCCL and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

MCCL

CURE

Popularity

Low

Low

Pearlers invested

10

83

Median incremental investment

$649.50

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,900.80

$1,456.00

Average age group

26 - 35

> 35


Key Summary

MCCL

CURE

Strategy

MCCL.AX was created on 2022-01-20 by Munro. The fund's investment portfolio concentrates primarily on theme equity. The Fund is to maximise long term capital appreciation, by investing primarily in a concentrated long-only portfolio of companies focused on decarbonisation and climate change located anywhere in the world. The Fund aims to achieve a return greater than the MSCI All Country World (Net) Index in $A (Net) over a 5 to 7 year period

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

Munro Climate Change Leaders Fund Active ETF (100 %)

Natera Inc (3.33 %)

Incyte Corp (2.96 %)

Gilead Sciences Inc (2.80 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.9 %

0.45 %


Key Summary

MCCL

CURE

Issuer

Munro

Global X

Tracking index

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.9 %

0.45 %

Price

$17.74

$51.97

Size

N/A

$36.301 million

10Y return

N/A

N/A

Annual dividend/ distribution yield (5Y)

0.06 %

4.24 %

Market

ASX

ASX

First listed date

19/01/2022

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

MCCL

CURE

Popularity

Low

Low

Pearlers invested

10

83

Median incremental investment

$649.50

$619.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,900.80

$1,456.00

Average age group

26 - 35

> 35


Pros and Cons

MCCL

CURE

Pros

  • Higher price growth

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower distribution yield

  • Lower price growth

MCCL

CURE

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home